Current status and future direction of surgical treatment for non-small cell lung cancer.
作者： Ichiro Yoshino
DOI:
关键词:
摘要: Lung cancer in Japan has been a leading cause of cancer-related deaths since 1998, though therapeutic outcomes have gradually improved. Better prognoses resulted from an increase female adenocarci-noma (i.e., well-differentiated papillary adenocarcinoma or nonmucinous type bronchiole-alveolar carci-noma), which is known to low potential malignancy and be frequently detected at early stage,
researchgate.net 参考文章(12)
K. S. Albain, R. S. Swann, V. R. Rusch, A. T. Turrisi, F. A. Shepherd, C. J. Smith, D. R. Gandara, D. H. Johnson, M. R. Green, R. C. Miller, Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309) Journal of Clinical Oncology. ,vol. 23, pp. 7014- 7014 ,(2005) , 10.1200/JCO.2005.23.16_SUPPL.7014
Ken A Olaussen, Ariane Dunant, Pierre Fouret, Elisabeth Brambilla, Fabrice André, Vincent Haddad, Estelle Taranchon, Martin Filipits, Robert Pirker, Helmut H Popper, Rolf Stahel, Laure Sabatier, Jean-Pierre Pignon, Thomas Tursz, Thierry Le Chevalier, Jean-Charles Soria, None, DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. The New England Journal of Medicine. ,vol. 355, pp. 983- 991 ,(2006) , 10.1056/NEJMOA060570
Ichiro Yoshino, Hiromitsu Baba, Seiichi Fukuyama, Toshifumi Kameyama, Yasunori Shikada, Makiko Tomiyasu, Ryuichi Suemitsu, None, A time trend of profile and surgical results in 1123 patients with non-small cell lung cancer Surgery. ,vol. 131, pp. 242- 248 ,(2002) , 10.1067/MSY.2002.119796
Kazuhiro Yasufuku, Takahiro Nakajima, Taiki Fujiwara, Masako Chiyo, Akira Iyoda, Shigetoshi Yoshida, Makoto Suzuki, Yasuo Sekine, Kiyoshi Shibuya, Ichiro Yoshino, Role of endobronchial ultrasound-guided transbronchial needle aspiration in the management of lung cancer The Japanese Journal of Thoracic and Cardiovascular Surgery. ,vol. 56, pp. 268- 276 ,(2008) , 10.1007/S11748-008-0249-4
Tatsuo Ohira, Masahiro Tsuboi, Takashi Hirano, Jitsuo Usuda, Harubumi Kato, Tetsuya Okunaka, Kinya Furukawa, Hidemitsu Tsutsui, Kimito Yamada, Yasuhiro Suga, Hidetoshi Honda, Yoshitaka Nagatsuka, Photodynamic Therapy (PDT) for Lung Cancers Journal of Thoracic Oncology. ,vol. 1, pp. 489- 493 ,(2006) , 10.1016/S1556-0864(15)31616-6
Chi Wu, Huaijie Hao, Longyun Li, Xiaoyun Zhou, Zijian Guo, Li Zhang, Xiaotong Zhang, Wei Zhong, Huiqin Guo, Ross Macrae Bremner, Ping Lin, Preliminary Investigation of the Clinical Significance of Detecting Circulating Tumor Cells Enriched from Lung Cancer Patients Journal of Thoracic Oncology. ,vol. 4, pp. 30- 36 ,(2009) , 10.1097/JTO.0B013E3181914125
Harubumi Kato, Yukito Ichinose, Morio Ohta, Enjo Hata, Noriaki Tsubota, Hirohito Tada, Yoh Watanabe, Hiromi Wada, Masahiro Tsuboi, Nobuyuki Hamajima, Mitsuo Ohta, A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung The New England Journal of Medicine. ,vol. 350, pp. 1713- 1721 ,(2004) , 10.1056/NEJMOA032792
Benjamin Besse, Thierry Le Chevalier, Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer: A Fading Effect? Journal of Clinical Oncology. ,vol. 26, pp. 5014- 5017 ,(2008) , 10.1200/JCO.2008.18.1081
Jean-Pierre Pignon, Hélène Tribodet, Giorgio V. Scagliotti, Jean-Yves Douillard, Frances A. Shepherd, Richard J. Stephens, Ariane Dunant, Valter Torri, Rafael Rosell, Lesley Seymour, Stephen G. Spiro, Estelle Rolland, Roldano Fossati, Delphine Aubert, Keyue Ding, David Waller, Thierry Le Chevalier, Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group Journal of Clinical Oncology. ,vol. 26, pp. 3552- 3559 ,(2008) , 10.1200/JCO.2007.13.9030
Koji Tsuta, Seiichiro Yamamoto, Hiroshi Nokihara, Noboru Yamamoto, Ikuo Sekine, Hideo Kunitoh, Koh Furuta, Tomohide Tamura, Toshimi Takano, Tomoya Fukui, Yuichiro Ohe, EGFR Mutations Predict Survival Benefit From Gefitinib in Patients With Advanced Lung Adenocarcinoma: A Historical Comparison of Patients Treated Before and After Gefitinib Approval in Japan Journal of Clinical Oncology. ,vol. 26, pp. 5589- 5595 ,(2008) , 10.1200/JCO.2008.16.7254